Back

Low level transcutaneous vagus nerve stimulation reverses cardiac dysfunction and changes left ventricular gene expression in a rat model of heart failure with preserved ejection fraction

30 August 2021 (07:15 - 07:24)
Organised by:
Congress Presentation Part of: Novel therapies for heart failure in the early pipeline Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Monika Niewiadomska

University of Oklahoma Health Sciences Center, Oklahoma City (United States of America)

2 More presentations in this session

Presentation thumbnail
Empagliflozin improves prognosis and energetic properties through modulating mitochondrial function in failing murine hearts
Professor A. Shiraki (Saga, JP)
Abstract Slides Video
Presentation thumbnail
Therapeutic role of Prostaglandin E2 receptor 4 stimulation in inflammatory cardiomyopathy
Doctor T. Akira (Yokohama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel therapies for heart failure in the early pipeline

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 07:15 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources